ROYAL BANK OF CANADA - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 26 filers reported holding CANCER GENETICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$4,0000.0%35,000
+45.8%
0.00%
Q2 2019$4,000
-50.0%
24,000
-29.4%
0.00%
Q1 2019$8,00034,000
+377677.8%
0.00%
Q4 2017$0
-100.0%
9
-98.9%
0.00%
Q3 2017$2,000
-90.5%
809
-84.7%
0.00%
Q2 2017$21,000
-4.5%
5,276
-1.3%
0.00%
Q1 2017$22,0005,344
+5409.3%
0.00%
Q2 2016$097
+273.1%
0.00%
Q3 2015$0260.0%0.00%
Q2 2015$0
-100.0%
26
-99.0%
0.00%
Q1 2015$20,000
+1900.0%
2,500
+5002.0%
0.00%
Q2 2014$1,000
-90.0%
49
-93.5%
0.00%
Q4 2013$10,0007500.00%
Other shareholders
CANCER GENETICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 22,203$148,0002.90%
Millrace Asset Group, Inc. 187,184$1,250,0001.30%
Sterneck Capital Management, LLC 60,650$405,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$560,0000.15%
Quality Growth Management, Inc. 23,500$157,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$334,0000.05%
DIKER MANAGEMENT LLC 35,015$234,0000.05%
SSI INVESTMENT MANAGEMENT LLC 65,043$434,0000.04%
BANK OF MONTREAL /CAN/ 616,430$4,118,0000.01%
Commonwealth Equity Services, Inc 27,100$181,0000.00%
View complete list of CANCER GENETICS INC shareholders